A citation-based method for searching scientific literature

Klara Lhotova, Lenka Stolarova, Petra Zemankova, Michal Vocka, Marketa Janatova, Marianna Borecka, Marta Cerna, Sandra Jelinkova, Jan Kral, Zuzana Volkova, Marketa Urbanova, Petra Kleiblova, Eva Machackova, Lenka Foretova, Jana Hazova, Petra Vasickova, Filip Lhota, Monika Koudova, Leona Cerna, Spiros Tavandzis, Jana Indrakova, Lucie Hruskova, Marcela Kosarova, Radek Vrtel, Viktor Stranecky, Stanislav Kmoch, Michal Zikan, Libor Macurek, Zdenek Kleibl, Jana Soukupova. Cancers (Basel) 2020
Times Cited: 4







List of co-cited articles
9 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
75

A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
Saundra S Buys, John F Sandbach, Amanda Gammon, Gayle Patel, John Kidd, Krystal L Brown, Lavania Sharma, Jennifer Saam, Johnathan Lancaster, Mary B Daly. Cancer 2017
168
50

Landscape of pathogenic variations in a panel of 34 genes and cancer risk estimation from 5131 HBOC families.
Laurent Castéra, Valentin Harter, Etienne Muller, Sophie Krieger, Nicolas Goardon, Agathe Ricou, Antoine Rousselin, Germain Paimparay, Angelina Legros, Olivia Bruet,[...]. Genet Med 2018
33
50

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
Tom Walsh, Silvia Casadei, Ming K Lee, Christopher C Pennil, Alex S Nord, Anne M Thornton, Wendy Roeb, Kathy J Agnew, Sunday M Stray, Anneka Wickramanayake,[...]. Proc Natl Acad Sci U S A 2011
564
50

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
50

Hereditary breast and ovarian cancer: new genes in confined pathways.
Finn Cilius Nielsen, Thomas van Overeem Hansen, Claus Storgaard Sørensen. Nat Rev Cancer 2016
175
50

Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D.
Xin Yang, Honglin Song, Goska Leslie, Christoph Engel, Eric Hahnen, Bernd Auber, Judit Horváth, Karin Kast, Dieter Niederacher, Clare Turnbull,[...]. J Natl Cancer Inst 2020
21
50

Hereditary truncating mutations of DNA repair and other genes in BRCA1/BRCA2/PALB2-negatively tested breast cancer patients.
F Lhota, P Zemankova, P Kleiblova, J Soukupova, M Vocka, V Stranecky, M Janatova, H Hartmannova, K Hodanova, S Kmoch,[...]. Clin Genet 2016
26
50

Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes.
Jana Soukupova, Petra Zemankova, Klara Lhotova, Marketa Janatova, Marianna Borecka, Lenka Stolarova, Filip Lhota, Lenka Foretova, Eva Machackova, Viktor Stranecky,[...]. PLoS One 2018
13
50

Inherited Mutations in Women With Ovarian Carcinoma.
Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger,[...]. JAMA Oncol 2016
335
25

Structural insights into the catalysis and regulation of E3 ubiquitin ligases.
Lori Buetow, Danny T Huang. Nat Rev Mol Cell Biol 2016
195
25

Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes.
Laurent Castéra, Sophie Krieger, Antoine Rousselin, Angélina Legros, Jean-Jacques Baumann, Olivia Bruet, Baptiste Brault, Robin Fouillet, Nicolas Goardon, Olivier Letac,[...]. Eur J Hum Genet 2014
155
25

First description of a double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient: A case report.
Guillaume Meynard, Laura Mansi, Pierre Lebahar, Cristian Villanueva, Elodie Klajer, Fabien Calcagno, Adrian Vivalta, Marie Chaix, Marie-Agnès Collonge-Rame, Céline Populaire,[...]. Oncol Rep 2017
5
25

The mutational constraint spectrum quantified from variation in 141,456 humans.
Konrad J Karczewski, Laurent C Francioli, Grace Tiao, Beryl B Cummings, Jessica Alföldi, Qingbo Wang, Ryan L Collins, Kristen M Laricchia, Andrea Ganna, Daniel P Birnbaum,[...]. Nature 2020
25

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.
M William Audeh, James Carmichael, Richard T Penson, Michael Friedlander, Bethan Powell, Katherine M Bell-McGuinn, Clare Scott, Jeffrey N Weitzel, Ana Oaknin, Niklas Loman,[...]. Lancet 2010
932
25

A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2.
S J Ramus, L S Friedman, S A Gayther, B A Ponder, L Bobrow, M van der Looji, J Papp, E Olah. Nat Genet 1997
59
25

The BARD1 Cys557Ser variant and risk of familial breast cancer in a South-American population.
Patricio Gonzalez-Hormazabal, Jose M Reyes, Rafael Blanco, Teresa Bravo, Ignacio Carrera, Octavio Peralta, Fernando Gomez, Enrique Waugh, Sonia Margarit, Gladys Ibañez,[...]. Mol Biol Rep 2012
17
25

Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline.
Nadine M Tung, Judy C Boughey, Lori J Pierce, Mark E Robson, Isabelle Bedrosian, Jill R Dietz, Anthony Dragun, Judith Balmana Gelpi, Erin W Hofstatter, Claudine J Isaacs,[...]. J Clin Oncol 2020
48
25


Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.
Susan J Ramus, Honglin Song, Ed Dicks, Jonathan P Tyrer, Adam N Rosenthal, Maria P Intermaggio, Lindsay Fraser, Aleksandra Gentry-Maharaj, Jane Hayward, Susan Philpott,[...]. J Natl Cancer Inst 2015
201
25

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
Huong D Meeks, Honglin Song, Kyriaki Michailidou, Manjeet K Bolla, Joe Dennis, Qin Wang, Daniel Barrowdale, Debra Frost, Lesley McGuffog, Steve Ellis,[...]. J Natl Cancer Inst 2015
59
25

Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial.
Milagros González-Rivera, Miriam Lobo, Sara López-Tarruella, Yolanda Jerez, María Del Monte-Millán, Tatiana Massarrah, Rocío Ramos-Medina, Inmaculada Ocaña, Antoni Picornell, Sonia Santillán Garzón,[...]. Breast Cancer Res Treat 2016
21
25

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.
Sharon E Plon, Diana M Eccles, Douglas Easton, William D Foulkes, Maurizio Genuardi, Marc S Greenblatt, Frans B L Hogervorst, Nicoline Hoogerbrugge, Amanda B Spurdle, Sean V Tavtigian. Hum Mutat 2008
542
25

Clinical significance of morphologic characteristics in triple negative breast cancer.
Dong Won Ryu, Min Jung Jung, Woo Sik Choi, Chung Han Lee. J Korean Surg Soc 2011
8
25

Functional analysis of clinical BARD1 germline variants.
Ming Ren Toh, Siao Ting Chong, Sock Hoai Chan, Chen Ee Low, Nur Diana Binte Ishak, Jing Quan Lim, Eliza Courtney, Joanne Ngeow. Cold Spring Harb Mol Case Stud 2019
3
33

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
Panagiotis A Konstantinopoulos, Barbara Norquist, Christina Lacchetti, Deborah Armstrong, Rachel N Grisham, Paul J Goodfellow, Elise C Kohn, Douglas A Levine, Joyce F Liu, Karen H Lu,[...]. J Clin Oncol 2020
44
25

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Fergus J Couch, Hermela Shimelis, Chunling Hu, Steven N Hart, Eric C Polley, Jie Na, Emily Hallberg, Raymond Moore, Abigail Thomas, Jenna Lilyquist,[...]. JAMA Oncol 2017
269
25

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.
Jonathan Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Gordon Rustin, Clare L Scott, Werner Meier, Ronnie Shapira-Frommer, Tamar Safra,[...]. Lancet Oncol 2014
841
25

Age-adjusted association of homologous recombination genes with ovarian cancer using clinical exomes as controls.
Kevin J Arvai, Maegan E Roberts, Rebecca I Torene, Lisa R Susswein, Megan L Marshall, Zhancheng Zhang, Natalie J Carter, Lauren Yackowski, Erica S Rinella, Rachel T Klein,[...]. Hered Cancer Clin Pract 2019
4
25

Cancer predisposing missense and protein truncating BARD1 mutations in non-BRCA1 or BRCA2 breast cancer families.
Sylvia De Brakeleer, Jacques De Grève, Remy Loris, Nicolas Janin, Willy Lissens, Erica Sermijn, Erik Teugels. Hum Mutat 2010
59
25

Prevalence of germline variants in inflammatory breast cancer.
Huma Q Rana, Rosalba Sacca, Christine Drogan, Stephanie Gutierrez, Emily Schlosnagle, Meredith M Regan, Virginia Speare, Holly LaDuca, Jill Dolinsky, Judy E Garber,[...]. Cancer 2019
8
25

Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains.
Y Jin, X L Xu, M C Yang, F Wei, T C Ayi, A M Bowcock, R Baer. Proc Natl Acad Sci U S A 1997
142
25

Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer.
Clara Esteban-Jurado, Maria Vila-Casadesús, Pilar Garre, Juan José Lozano, Anna Pristoupilova, Sergi Beltran, Jenifer Muñoz, Teresa Ocaña, Francesc Balaguer, Maria López-Cerón,[...]. Genet Med 2015
63
25

Pan-cancer patterns of somatic copy number alteration.
Travis I Zack, Stephen E Schumacher, Scott L Carter, Andre D Cherniack, Gordon Saksena, Barbara Tabak, Michael S Lawrence, Cheng-Zhong Zhsng, Jeremiah Wala, Craig H Mermel,[...]. Nat Genet 2013
974
25

Mutation prevalence tables for hereditary cancer derived from multigene panel testing.
Steven N Hart, Eric C Polley, Amal Yussuf, Siddhartha Yadav, David E Goldgar, Chunling Hu, Holly LaDuca, Laura P Smith, June Fujimoto, Shuwei Li,[...]. Hum Mutat 2020
5
25

Characterization of a novel founder MSH6 mutation causing Lynch syndrome in the French Canadian population.
E Castellsagué, J Liu, A Volenik, S Giroux, R Gagné, B Maranda, A Roussel-Jobin, J Latreille, R Laframboise, L Palma,[...]. Clin Genet 2015
10
25

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
994
25

Role of BRCA Mutations in the Modulation of Response to Platinum Therapy.
Sanghamitra Mylavarapu, Asmita Das, Monideepa Roy. Front Oncol 2018
43
25

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.
Kelly L Bolton, Georgia Chenevix-Trench, Cindy Goh, Siegal Sadetzki, Susan J Ramus, Beth Y Karlan, Diether Lambrechts, Evelyn Despierre, Daniel Barrowdale, Lesley McGuffog,[...]. JAMA 2012
361
25


Identification of germline alterations in breast cancer predisposition genes among Malaysian breast cancer patients using panel testing.
P S Ng, W X Wen, M Z H Fadlullah, S Y Yoon, S Y Lee, M K Thong, C H Yip, N A Mohd Taib, S H Teo. Clin Genet 2016
9
25

Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population.
Simone da Costa E Silva Carvalho, Nathalia Moreno Cury, Danielle Barbosa Brotto, Luiza Ferreira de Araujo, Reginaldo Cruz Alves Rosa, Lorena Alves Texeira, Jessica Rodrigues Plaça, Adriana Aparecida Marques, Kamila Chagas Peronni, Patricia de Cássia Ruy,[...]. BMC Med Genomics 2020
9
25

Mutational analysis of BARD1 in familial breast cancer patients in Japan.
Makoto Ishitobi, Yasuo Miyoshi, Seiichi Hasegawa, Chiyomi Egawa, Yasuhiro Tamaki, Morito Monden, Shinzaburo Noguchi. Cancer Lett 2003
51
25

Genomic analysis of inherited breast cancer among Palestinian women: Genetic heterogeneity and a founder mutation in TP53.
Suhair Lolas Hamameh, Paul Renbaum, Lara Kamal, Dima Dweik, Mohammad Salahat, Tamara Jaraysa, Amal Abu Rayyan, Silvia Casadei, Jessica B Mandell, Suleyman Gulsuner,[...]. Int J Cancer 2017
16
25

Functional analysis of BARD1 missense variants in homology-directed repair and damage sensitivity.
Aleksandra I Adamovich, Tapahsama Banerjee, Margaret Wingo, Kathryn Duncan, Jie Ning, Fernanda Martins Rodrigues, Kuan-Lin Huang, Cindy Lee, Feng Chen, Li Ding,[...]. PLoS Genet 2019
10
25


H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.
Kyosuke Nakamura, Giulia Saredi, Jordan R Becker, Benjamin M Foster, Nhuong V Nguyen, Tracey E Beyer, Laura C Cesa, Peter A Faull, Saulius Lukauskas, Thomas Frimurer,[...]. Nat Cell Biol 2019
48
25

Lack of association between BARD1 Cys557Ser variant and breast cancer risk: a meta-analysis of 11,870 cases and 7,687 controls.
Da-Peng Ding, Ying Zhang, Wen-Li Ma, Xiao-Feng He, Wei Wang, Hai-Lang Yu, Yu-Bo Guo, Wen-Ling Zheng. J Cancer Res Clin Oncol 2011
9
25

Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predisposition.
E Rouleau, B Jesson, A Briaux, C Nogues, V Chabaud, L Demange, J Sokolowska, F Coulet, E Barouk-Simonet, Y J Bignon,[...]. Breast Cancer Res Treat 2012
17
25

Contribution of the PALB2 c.2323C>T [p.Q775X] founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent.
Marc Tischkowitz, Nelly Sabbaghian, Nancy Hamel, Carly Pouchet, William D Foulkes, Anne-Marie Mes-Masson, Diane M Provencher, Patricia N Tonin. BMC Med Genet 2013
13
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.